HUAWEI
Today Huawei Consumer Business Group unveiled the HUAWEI P20 Series. The HUAWEI P20 Pro features the world’s first Leica triple camera and both devices include unprecedented AI advances, combining technology and art to bring to life a groundbreaking smartphone experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180327005811/en/
“We look for inspiration from artists to continuously evolve our approach to design and innovation,” said Richard Yu, Chief Executive Officer, Huawei Consumer Business Group. “With a breakthrough triple camera on the HUAWEI P20 Pro, an advanced dual camera on the HUAWEI P20 and powerful artificial intelligence on both, today’s most vibrant consumers can capture and share the brilliance of the world around them.”
Key features of the HUAWEI P20 Series include:
- An advanced camera to capture more light, featuring a Leica triple camera and 5x Hybrid Zoom on the HUAWEI P20 Pro, and a Leica dual camera on the HUAWEI P20, both achieving DxOMark’s highest overall scores1 ;
- Innovative photography features, including AI-powered professional photography features and HUAWEI AIS (AI Image Stabilization);
- A timeless design with barely-there bezels and all-new gradient colors;
- Ultimate performance, featuring the NPU on Kirin 970 and EMUI 8.1 based on Android™ 8.1.
A Combination of Art and Technology
The HUAWEI P20 Series comes in Black, Midnight Blue and two all-new gradient colors, Twilight and Pink Gold, achieved by applying several layers of NCVM* optical coatings underneath the glass back, so light hitting the surface refracts and creates a vivid, yet gradual change of hue.
The 5.8-inch screen HUAWEI P20 and 6.1-inch screen HUAWEI P20 Pro feature HUAWEI FullView Display, ultra-thin bezels and impressive screen-to-body ratios for better viewing experiences.
Inspired by Light and Technology
The HUAWEI P20 Pro features a Leica triple camera with the highest total pixel count on a smartphone – the camera configuration is comprised of a 40MP RGB sensor, a 20MP monochrome sensor and an 8MP sensor with telephoto lens. It also features an exclusive Leica color temperature sensor for better color reproduction. With f/1.8, f/1.6 and f/2.4 wide aperture to capture crisp, clear details, the HUAWEI P20 Pro also includes a brand new Leica 3x telephoto (VARIO-SUMMILUX-H 1:1.6-2.4/27-80ASPH) lens for long-range photography of up to 5x Hybrid Zoom. The HUAWEI P20 Pro’s highly sensitive image sensor captures low light photos with up to ISO 102400.
The HUAWEI P20 builds on its predecessor’s foundation with a Leica dual camera featuring a 12MP sensor with a pixel size as high as 1.55 μm, and a 20MP monochrome sensor, enhancing the HUAWEI P20’s ability to capture photos in low-light settings.
The HUAWEI P20 Series devices support six-axis stabilization and 960fps super slow motion. With Ultra Snapshot mode, the devices can capture an image in as little as 0.3 seconds by just double clicking the down volume button, even from an off screen.
Master AI Photography Experience
With the Kirin 970 processor, the HUAWEI P20 Series automatically identifies more than 500 scenarios in 19 categories, selecting camera settings to deliver professional-looking images. HUAWEI AIS steadies handheld night shots for incredible long exposure images without a tripod. Brand new to Huawei’s advanced camera system is 4D predictive focus, predicting moving objects and focusing on them with extreme efficiency to capture minute detail. The HUAWEI P20 Series also features AI-Assisted Composition, providing intelligent suggestions to frame group shots and landscapes.
The HUAWEI P20 and HUAWEI P20 Pro feature a 24MP selfie camera** with AI beautification and 3D portrait lighting. The HUAWEI P20 Series also includes on-device Prisma processing, which supports real-time filter recommendations based on scene and object recognition.
In partnership with Google, the HUAWEI P20 Series supports Google ARCore, delivering advanced AR capabilities.
Collaboration with Porsche Design
Huawei also unveiled the PORSCHE DESIGN HUAWEI Mate RS. Continuing its collaboration with the exclusive luxury brand, the PORSCHE DESIGN HUAWEI Mate RS features Porsche Design’s signature functional design language and Huawei’s cutting-edge technology and craftsmanship, setting a new standard in premium smartphones.
Pricing and Availability
The HUAWEI P20 Series and PORSCHE DESIGN HUAWEI Mate RS are immediately available globally.
| Model | Version | EUR (includes tax) | ||||
| HUAWEI P20 | 4GB + 128GB |
€649 |
||||
| HUAWEI P20 Pro | 6GB + 128GB |
€899 |
||||
| PORSCHE DESIGN HUAWEI Mate RS | 6GB + 256GB |
€1,695 |
||||
| PORSCHE DESIGN HUAWEI Mate RS | 6GB + 512GB |
€2,095 |
||||
*Non-conductive Vacuum Metalizing
**24.8MP sensor
For more information please visit: https://consumer.huawei.com/en/
1 Highest overall DxOMark scores in the mobile camera category – HUAWEI P20 Pro: 109; HUAWEI P20: 102.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180327005811/en/
Contact:
Racepoint Global for Huawei Consumer BG
Lisa Kennedy, 1-415-694-6700
Huawei@racepointglobal.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom